Artemisinin treats SNU-C2A cell line for colorectal cancer by inhibiting cell growth through undergoing ferroptosis.

Abstract

Colorectal cancer is one of the major types of cancer that humans are suffering from; however, drugs that can be used for treatment with no side effects have still not been discovered. By research, Chinese traditional medicine called artemisinin (ART) was known for undergoing ferroptosis in cells. Therefore, some experimental tests need to verify the effect of whether artemisinin allows ferroptosis to apply to colorectal cancer cells. The result of this experiment can allow a better understanding of the direction of colorectal cancer treatment and how Chinese traditional medicine can perform as treatments for CRC. Therefore, during this experiment, ART was used to test ferroptosis in the SNU-C2A colorectal cell line to see whether it’s a suitable drug to use for CRC patients.